by Jordana Choucair | Oct 1, 2021 | Life Sciences
Merck & Co. said its experimental antiviral pill to treat COVID-19 reduced the risk of hospitalization and death by nearly half in a clinical trial. The results prompted an independent monitoring board to recommend the study end early because of the promising...
by Jordana Choucair | Sep 30, 2021 | Life Sciences
The CDC doubled down on its appeals for pregnant and breastfeeding people to get vaccinated, pointing to the higher risk that COVID-19 poses during pregnancy and data showing vaccination rates are lower among pregnant people than among the general population. The...
by Jordana Choucair | Sep 29, 2021 | Life Sciences
Americans who have received a third COVID-19 shot reported similar rates of side effects as they did after their second doses. According to CDC data through mid-September, most symptoms were mild to moderate, suggesting the extra shots are safe. (Articles here and...
by Jordana Choucair | Sep 28, 2021 | Life Sciences
Pfizer and BioNTech submitted data to the FDA on their COVID-19 vaccine for children ages 5 to 11. The companies said that they would formally ask within weeks that the shot be authorized for children in that age group. If regulators follow the same timeline they took...
by Jordana Choucair | Sep 27, 2021 | Life Sciences
Pfizer Inc. said it’s conducting a mid-to-late-stage clinical trial that is testing an antiviral pill to prevent COVID-19 among people who have been exposed to the virus. Merck & Co Inc. and Roche Holding AG are also developing COVID-19 antivirals. (Article...
by Jordana Choucair | Sep 24, 2021 | Life Sciences
A key CDC panel recommended the Pfizer-BioNTech COVID-19 booster shots for people 65 years old and older, as well as those at high risk of severe COVID-19. Contrary to the FDA, the panel rejected a plan that would have distributed the booster shots to people whose...
Recent Comments